![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.expresspharma.in/lupin-receives-approval-from-us-fda-for-meclizine-hydrochloride-tablets-usp/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203003
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-6-2022-1649740823.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200432
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-13-2021-1634124785.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213957
https://www.moneycontrol.com/news/business/zydus-cadila-gets-usfda-nod-to-market-generic-antihistamine-tablets-5449911.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-20-2019-1574236434.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-22-2017-1511333424.pdf
http://www.pharma-excipients.ch/2016/05/13/formulation-and-evaluation-of-meclizine-hcl-orally-dispersible-tablets-by-using-natural-super-disintegrants/
http://www.pharma-excipients.ch/2016/01/28/formulation-development-and-evaluation-of-meclozine-hydrochloridemicrospheres/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0510-2016&w=12162015&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0509-2016&w=12162015&lang=eng